Effects of manganese injected into rat nostrils: implications for in vivo functional study of olfaction using MEMRI

Benoist Lehallier1, Gérard Coureaud, Yves Maurin

  • 1UR370 QuaPA, INRA, F-63122 Saint-Genès-Champanelle, France.

Insights

This study found the optimal manganese dose for rat nasal injections in MRI studies. A 0.3 μmol dose enhances MRI contrast without impairing olfactory perception.

Area of Science:

  • Neuroscience
  • Biomedical Imaging
  • Toxicology

Background:

  • Manganese-enhanced magnetic resonance imaging (MEMRI) visualizes neural pathways but carries risks of manganese (Mn) toxicity.
  • Mn toxicity is influenced by its administration route, necessitating careful dose optimization.

Purpose of the Study:

  • To determine the effects of intranasal manganese chloride (MnCl2) doses on olfactory perception and MRI contrast enhancement in rats.
  • To identify an optimal Mn dose for reproducible MRI studies while minimizing toxicity.

Main Methods:

  • Rats received intranasal MnCl2 doses ranging from 0-8 μmol.
  • Behavioral tests quantified olfactory perception and motor activity within 2 hours post-injection.
  • MRI scans were performed after 16 hours of olfactory stimulation to assess contrast enhancement.

Main Results:

  • Intranasal Mn administration did not affect spontaneous motor activity.
  • Odor-related behaviors were dose-dependently reduced following Mn injection.
  • Optimal MRI contrast enhancement in the primary olfactory cortex was achieved with 0.3 μmol MnCl2, with minimal impact on olfactory perception.

Conclusions:

  • An intranasal dose of 0.3 μmol MnCl2 is optimal for MEMRI in rats.
  • This dose provides reproducible MRI contrast enhancement while preserving olfactory perception.
  • Careful dose selection is crucial for balancing MEMRI efficacy and minimizing Mn toxicity.

Related Concept Videos